Argus analyst David Toung upgraded Silk Road Medical to Buy from Hold with a $24 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SILK:
- Silk Road Medical expands TCAR portfolio with launch of tapered ENROUTE system
- Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
- Silk Road Medical price target raised to $23 from $20 at Stifel
- Silk Road Medical price target raised to $28 from $20 at Lake Street
- Silk Road Medical price target raised to $18 from $11 at Piper Sandler